This inventor holds 4 USPTO granted patents. Top assignee: Zhejiang Sukean Pharmaceutical Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Yajing Liu: Innovator in Tuberculosis Detection
Introduction
Yajing Liu is a prominent inventor based in Zhejiang, China. He has made significant contributions to the field of medical diagnostics, particularly in the detection of tuberculosis. With a total of 4 patents, Liu's work focuses on developing innovative solutions to combat drug-resistant strains of tuberculosis.
Latest Patents
Liu's latest patents include a set of serum metabolic biomarkers and a detection kit for drug-resistant tuberculosis. This kit comprises 17 serum metabolic biomarkers that have been verified to be associated with tuberculosis based on the level changes of these biomarkers. The metabolites include taurine, homocysteine, uric acid, and several others. This detection kit is crucial for assisting doctors in accurately diagnosing drug-resistant tuberculosis, which is vital for effective treatment and mass screening.
Another significant patent by Liu involves a set of serum metabolic biomarkers and a detection kit for general tuberculosis. This kit also includes 17 serum metabolic biomarkers, such as D-Leucic acid and Leucinic acid, which have shown a high level of accuracy in detecting tuberculosis. The detection model based on these biomarkers achieves an area under the ROC curve of 99.5%, with a sensitivity of 98.2% and specificity of 95.8%. This innovation is essential for improving diagnostic accuracy and facilitating mass screening efforts.
Career Highlights
Yajing Liu is currently associated with Zhejiang Sukean Pharmaceutical Co., Ltd. His work at this company has been instrumental in advancing tuberculosis diagnostics. Liu's innovative approaches have garnered attention in the medical community, highlighting the importance of his contributions to public health.
Collaborations
Liu has collaborated with notable colleagues, including Chao Zhang and Pintong Huang. These partnerships have further enhanced the development and implementation of his innovative diagnostic solutions.
Conclusion
Yajing Liu's contributions to tuberculosis detection through his innovative patents are paving the way for more effective diagnostic methods. His work is crucial in the fight against drug-resistant tuberculosis, ultimately improving patient outcomes and public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile